Applied DNA Sciences, Inc.
APDN
Price:
$1.2101
Market Cap:
$12.46M
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time aut...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2003-07-15
Stock Exchange
NASDAQ
Ticker
APDN
The ROE as of September 2024 (TTM) for Applied DNA Sciences, Inc. (APDN) is -136.86%
According to Applied DNA Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -136.86%. This represents a change of -105.95% compared to the average of 2.30% of the last 4 quarters.
Applied DNA Sciences, Inc. (APDN) Historical ROE (quarterly & annually)
How has APDN ROE performed in the past?
The mean historical ROE of Applied DNA Sciences, Inc. over the last ten years is -66.68%. The current -136.86% ROE has changed 105.26% with respect to the historical average. Over the past ten years (40 quarters), APDN's ROE was at its highest in in the March 2024 quarter at 9.28%. The ROE was at its lowest in in the September 2018 quarter at -460.61%.
Average
-66.68%
Median
-130.85%
Minimum
-1549.75%
Maximum
1.03%
Applied DNA Sciences, Inc. (APDN) ROE by Quarter and Year
Discovering the peaks and valleys of Applied DNA Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 726.74%
Maximum Annual ROE = 1.03%
Minimum Annual Increase = -332.23%
Minimum Annual ROE = -1549.75%
| Year | ROE | Change |
|---|---|---|
| 2023 | -200.90% | 209.62% |
| 2022 | -64.89% | -55.01% |
| 2021 | -144.23% | -35.39% |
| 2020 | -223.23% | -121.76% |
| 2019 | 1.03% | -166.20% |
| 2018 | -1549.75% | 726.74% |
| 2017 | -187.45% | 59.58% |
| 2016 | -117.47% | 24.25% |
| 2015 | -94.54% | -110.63% |
| 2014 | 889.81% | -332.23% |
Applied DNA Sciences, Inc. (APDN) Average ROE
How has APDN ROE performed in the past?
The current ROE of Applied DNA Sciences, Inc. (APDN) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-136.67%
5-year avg
78.53%
10-year avg
-66.68%
Applied DNA Sciences, Inc. (APDN) ROE vs. Peers
How is APDN’s ROE compared to its peers?
Applied DNA Sciences, Inc.’s ROE is greater than Biodesix, Inc. (-525.32%), greater than DarioHealth Corp. (-7.91%), greater than Olink Holding AB (publ) (-7.07%), greater than Genetron Holdings Limited (-36.51%), greater than Exagen Inc. (-78.90%), greater than Burning Rock Biotech Limited (-74.92%), greater than Neuronetics, Inc. (-109.00%), greater than Sera Prognostics, Inc. (-46.71%), greater than OncoCyte Corporation (-140.65%), greater than Personalis, Inc. (-63.43%), greater than Interpace Biosciences, Inc. (-10.70%), greater than iSpecimen Inc. (-115.37%), less than Trinity Biotech plc (95.19%), greater than Mainz Biomed B.V. (-489.37%), greater than Prenetics Global Limited (-29.80%), less than FONAR Corporation (9.60%),
| Company | ROE | Market cap |
|---|---|---|
| -525.32% | $261.32M | |
| -7.91% | $30.33M | |
| -7.07% | $3.24B | |
| -36.51% | $127.29M | |
| -78.90% | $48.86M | |
| -74.92% | $34.83M | |
| -109.00% | $28.14M | |
| -46.71% | $265.69M | |
| -140.65% | $39.97M | |
| -63.43% | $322.64M | |
| -10.70% | $7.25M | |
| -115.37% | $3.49M | |
| 95.19% | $17.19M | |
| -489.37% | $5.99M | |
| -29.80% | $53.69M | |
| 9.60% | $110.81M |
Build a custom stock screener for Applied DNA Sciences, Inc. (APDN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied DNA Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Applied DNA Sciences, Inc. (APDN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Applied DNA Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Applied DNA Sciences, Inc.'s ROE?
How is the ROE calculated for Applied DNA Sciences, Inc. (APDN)?
What is the highest ROE for Applied DNA Sciences, Inc. (APDN)?
What is the 3-year average ROE for Applied DNA Sciences, Inc. (APDN)?
What is the 5-year average ROE for Applied DNA Sciences, Inc. (APDN)?
How does the current ROE for Applied DNA Sciences, Inc. (APDN) compare to its historical average?